Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Solid Biosciences (SLDB) Change in Accured Expenses (2017 - 2024)

Solid Biosciences (SLDB) has disclosed Change in Accured Expenses for 8 consecutive years, with $1.6 million as the latest value for Q4 2024.

  • Quarterly Change in Accured Expenses rose 198.72% to $1.6 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $4.8 million through Dec 2024, up 168.41% year-over-year, with the annual reading at $4.0 million for FY2025, 15.02% down from the prior year.
  • Change in Accured Expenses hit $1.6 million in Q4 2024 for Solid Biosciences, down from $3.3 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $8.7 million in Q2 2022 to a low of -$5.0 million in Q3 2022.
  • Historically, Change in Accured Expenses has averaged $10950.0 across 5 years, with a median of -$341000.0 in 2021.
  • Biggest YoY gain for Change in Accured Expenses was 1515.01% in 2022; the steepest drop was 1544.37% in 2022.
  • Year by year, Change in Accured Expenses stood at $887000.0 in 2020, then soared by 190.42% to $2.6 million in 2021, then dropped by 0.27% to $2.6 million in 2022, then crashed by 164.03% to -$1.6 million in 2023, then surged by 198.72% to $1.6 million in 2024.
  • Business Quant data shows Change in Accured Expenses for SLDB at $1.6 million in Q4 2024, $3.3 million in Q3 2024, and -$380000.0 in Q2 2024.